As of 2024-10-09, the Fair Value of SAGE Therapeutics Inc (SAGE) is -36.50 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.43 USD, the upside of SAGE Therapeutics Inc is -667.62%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -680.20 | 606.10 | -457.90 | -532.80 | -541.49 | -321.26 |
| YoY growth | -82.41% | 189.11% | -175.55% | -16.36% | -1.63% | -17.37% |
| Market Cap (mil) | 392.55 |
| P/E | |
| Forward P/E |
| EPS | -7.30 |
| Avg earnings growth rate | -17.37% |
| TTM earnings | -445.64 |